MTHLAB
ActiveSummary
MTHLAB has been active since 2019 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €479,399 and a net result of €316,801. Equity has been growing by about 21% per year since 2019. The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Overview
Official details
Source: KBO- Status
- Active since 29-03-2019 Normal situation
- Activity
- “Toutes opérations se rapportant directement ou indirectement à l’analyse médicale, la biologie clinique, la…” (deed in French)From the articles, 2 activitiesNo NACE code in the KBO yet
- Establishment unit
- 2.288.107.165 1180 Ukkel, since 29-03-2019
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.1%
- Gross margin
- €419,515
- ▲ 102%
- Turnover
- ≈ €840,000
- estimated
- Profit
- €316,801
- ▲ 102%
- Equity
- €479,399
- ▲ 195%
- Total assets
- €502,986
- ▲ 7.8%
- 2025 accounts filed 45 days after the deadline
Score breakdownraises riskLast filed accounts filed 45 days late; 2 of the last 3 accounts latelowers riskSize: total assets €502,986Liquidity: current ratio 21.20, cash €306,831Equity €479,399 (95.3% of total assets)Show the evidence
Checked score
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 95% on liquidity, 90% on profitability and 96% on growth.
The bankruptcy probability was computed on 02-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 7 accounts on average 74 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Financials
Financials · financial year 2025, micro format
2025 annual accounts filed 45 days after the deadline Filed on 14 September 2026, deadline 31 July 2026 (7 months after the close on 31 December 2025, Companies Code art. 3:10). Source: NBB, 2026-00514611.
Annual accounts 2025 filed on 14-09-2026 at the NBB all 7 filings
Every figure per financial year
The operating result for 2025 is 103% higher than in 2024 and the highest since 2021. It is the third rise in a row, after the fall in 2022.
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Investments
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Tangible fixed assets | - | €1,749 | - | - | €2,688 |
| Depreciation and write-downs of the year | €8,209 | €7,761 | €8,137 | €437 | €518 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €10,598 | €8,209 | €8,209 | €7,761 | €8,137 | €437 | €518 | ▲ 18.5% |
| Other operating charges640/8 | - | - | €954 | €856 | €853 | €1,103 | €617 | ▼ 44.1% |
| Gross operating margin9900 | €75,026 | €74,610 | €137,793 | €105,100 | €108,554 | €207,594 | €419,515 | ▲ 102% |
| Operating profit (loss)9901 | €63,730 | €65,587 | €128,630 | €96,483 | €99,563 | €206,054 | €418,379 | ▲ 103% |
| Financial income75/76B | - | - | - | - | €3 | - | - | - |
| Recurring financial income75 | €22 | - | - | - | €3 | - | - | - |
| Financial charges65/66B | - | - | €109 | €78 | €125 | €91 | €258 | ▲ 182% |
| Recurring financial charges65 | €25 | €59 | €109 | €78 | €125 | €91 | €258 | ▲ 182% |
| Profit (loss) for the period before taxes9903 | €63,727 | €65,527 | €128,521 | €96,405 | €99,442 | €205,963 | €418,122 | ▲ 103% |
| Income taxes67/77 | €18,012 | €22,869 | €37,071 | €19,697 | €15,313 | €49,414 | €101,321 | ▲ 105% |
| Profit (loss) for the period9904 | €45,715 | €42,658 | €91,451 | €76,709 | €84,129 | €156,549 | €316,801 | ▲ 102% |
| Profit (loss) for the period to be appropriated9905 | €45,715 | €42,658 | €91,451 | €76,709 | €84,129 | €156,549 | €316,801 | ▲ 102% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Total assets20/58 | €95,072 | €152,573 | €231,292 | €286,942 | €295,433 | €466,640 | €502,986 | ▲ 7.8% |
| Fixed assets21/28 | €31,817 | €23,609 | €15,400 | €9,388 | €1,251 | €813 | €2,983 | ▲ 267% |
| Tangible fixed assets22/27 | €31,817 | €23,609 | €15,400 | €9,388 | €1,251 | €813 | €2,983 | ▲ 267% |
| Furniture and vehicles24 | - | - | €15,400 | €9,388 | €1,251 | €813 | €2,983 | ▲ 267% |
| Current assets29/58 | €63,255 | €128,965 | €215,892 | €277,554 | €294,182 | €465,827 | €500,002 | ▲ 7.3% |
| Amounts receivable within one year40/41 | - | - | - | €11,324 | €16,353 | €112,013 | €173,983 | ▲ 55.3% |
| Trade receivables40 | - | - | - | €521 | - | €106,463 | €173,983 | ▲ 63.4% |
| Other amounts receivable41 | - | - | - | €10,803 | €16,353 | €5,549 | - | - |
| Cash at bank and in hand54/58 | €50,112 | €116,140 | €203,676 | €239,310 | €254,364 | €333,059 | €306,831 | ▼ 7.9% |
| Deferred charges and accrued income490/1 | - | - | €12,216 | €26,920 | €23,466 | €20,755 | €19,188 | ▼ 7.5% |
| Equity and liabilities | ||||||||
| Total equity and liabilities10/49 | €95,072 | €152,573 | €231,292 | €286,942 | €295,433 | €466,640 | €502,986 | ▲ 7.8% |
| Equity10/15 | €63,503 | €105,361 | €196,012 | €196,720 | €200,849 | €162,598 | €479,399 | ▲ 195% |
| Contributions10/11 | €18,600 | - | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €44,800 | €86,600 | €177,200 | €177,200 | €177,200 | €132,400 | €132,400 | = |
| Distributable reserves133 | - | - | €177,200 | €177,200 | €177,200 | €132,400 | €132,400 | = |
| Profit (loss) carried forward14 | €103 | €161 | €212 | €920 | €5,049 | €11,598 | €328,399 | ▲ 28× |
| Amounts payable17/49 | €31,570 | €47,212 | €35,280 | €90,221 | €94,584 | €304,042 | €23,587 | ▼ 92.2% |
| Amounts payable within one year42/48 | €31,570 | €47,212 | €35,280 | €90,221 | €94,584 | €304,042 | €23,587 | ▼ 92.2% |
| Trade debts44 | €172 | €5,814 | €8,217 | €5,764 | €5,383 | - | €6,598 | - |
| Suppliers440/4 | - | - | €8,217 | €5,764 | €5,383 | - | €6,598 | - |
| Taxes, remuneration and social security45 | - | - | €23,449 | €19,192 | €20,000 | €63,816 | €15,321 | ▼ 76.0% |
| Taxes450/3 | - | - | €23,449 | €19,192 | €12,000 | €55,816 | €7,321 | ▼ 86.9% |
| Remuneration and social security454/9 | - | - | - | - | €8,000 | €8,000 | €8,000 | = |
| Other amounts payable47/48 | - | - | €3,614 | €65,266 | €69,200 | €240,226 | €1,668 | ▼ 99.3% |
| Line | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €45,715 | €42,658 | €91,451 | €76,709 | €84,129 | €156,549 | €316,801 | ▲ 102% |
| + Depreciation and write-downs630 | €10,598 | €8,209 | €8,209 | €7,761 | €8,137 | €437 | €518 | ▲ 18.5% |
| Operating cash flow (approximation) | €56,313 | €50,867 | €99,659 | €84,470 | €92,266 | €156,986 | €317,319 | ▲ 102% |
| Investment in fixed assets (approximation) | - | €0 | €0 | -€1,749 | €0 | €0 | -€2,688 | - |
| Change in cash | - | €66,029 | €87,535 | €35,634 | €15,054 | €78,695 | -€26,228 | - |
A Belgian filing has no cash-flow statement. These rows are therefore an approximation, derived from the income statement and the balance-sheet moves.
Historical observation
In July 2024, 6,782 companies had the same profile as MTHLAB has now. Two years later, 96.7% were still going and 0.6% had gone bankrupt.
- Small
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
That fits the bankruptcy probability of MTHLAB itself: 0.1% within 12 months.
Test of the method
The method was tested on the 497,446 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,782 companies, not a prediction for MTHLAB. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Filings with the National Bank (7)
| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 14-09-2026 | 2026-00514611 | |
| 31-12-2024 | micro format | 28-08-2025 | 2025-00474388 | |
| 31-12-2023 | micro format | 07-10-2024 | 2024-00503895 | |
| 31-12-2022 | micro format | 18-09-2023 | 2023-00450816 | |
| 31-12-2021 | micro format | 10-11-2022 | 2022-20519146 | |
| 31-12-2020 | micro format | 10-11-2021 | 2021-77100118 | |
| 31-12-2019 | micro format | 04-12-2020 | 2020-74800184 |
Board & ownership
Directors
Owners and capital
Capital transactions
- 20-12-2023 Converted to unavailable equity · €18,600
Articles of association
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- “Article 14 - Rémunération des administrateurs, frais généraux, indépendamment frais représentation-voyages-déplacements”
Articles of association, deed of 20-12-2023 (in French)
Network & group
MTHLAB shares no director with another company.
Connections & network
1 current directorThe network starts from the directors of MTHLAB. Every other company they run is a node.
Timeline
Acts, filings and financial milestones
20-12
Gazette deed
Reappointment: Marie TRÉ-HARDY (director)Legal form clause · Capital conversion · Amendment of the articles10 points ▸
- General meeting, 14-12-2023
- Other provision, “statuts non modifiés, statuts n’ont pas été modifiés à ce jour” (deed in French)
- Legal form clause, “conservation, société à responsabilité limitée (SRL)” (deed in French)
- Capital conversion, “compte de capitaux propres statutairement indisponible” (deed in French)
- Other provision, “suppression du compte de capitaux propres statutairement indisponible, fonds disponibles pour distribution” (deed in French)
- Amendment of the articles
- Kind of shares, “en rémunération des apports”, 100 (deed in French)
- Director reappointment, Marie TRÉ-HARDY (director (not named in the articles))
- Registered office clause, “1180 Uccle,Avenue d'Andrimont 52” (deed in French)
- Other provision, “article 173-1°bis Code des Droits d'Enregistrement, délivrance avant enregistrement” (deed in French)
Show earlier events
Sources:Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Register details
Identity
KBO recordRegistered office and establishments
Activities
2 activities
- Toutes opérations se rapportant directement ou indirectement à l’analyse médicale, la biologie clinique, la biologie moléculaire, la microbiologie, la pharmacologie, l’hématologie, et toutes activités médicales, paramédicales et techniques s’y rapportant ainsi que la prestation de conseils y étant liées.
- Les prestations d’analyse de laboratoire visées par les articles 24 paragraphe 7 et 33 paragraphe 4 de la nomenclature des soins de santé, effectuées dans le domaine de la médecine humaine soit par des médecins ou pharmaciens biologies soit par les licenciés en sciences chimiques habilités à cet effet et liées au traitement d’un malade.
Invoicing and payment
Financial year and general meeting
Accounts at the NBBSites & property
Buildings and parcels at the address
| Cadastral parcel | Region | Area | Buildings | Height / floors |
|---|---|---|---|---|
| 21612D0493/00L007 | Brussels | 351 m² | 1 · 118 m² | 10.4 m · 3 |